Jiumeng Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jiumeng Zhang has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Xuli Feng
Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, China
4 shared publications Ling Xiang
Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, China
3 shared publicationsRumeng Cao
Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, China
3 shared publicationsHui Chen
Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, China
2 shared publicationsLan Yang
Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, China
2 shared publicationsShaofeng Chen
Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, China
2 shared publications
Latest Publications
- 23 April 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (37) , 9378-9390
Endogenous stimuli-responsive intelligent drug delivery systems: recent advances in cleavable linker design
Controllable drug release at target sites represents an important challenge in precision medicine. With advances in chemistry, materials, and biology, novel stimuli-responsive systems are being designed and fabricated for applications in biomedicine and pharmaceuticals. Endogenous biochemical signals, such as specific enzymes, pH, redox, and other species, provide natural targets for the development of stimuli-responsive intelligent drug delivery systems (DDSs). This review deeply analyzes the cleavable linkers that utilize these signals to trigger drug release. We explore the molecular design principles, chemical cleavage mechanisms, structure–activity relationships, and the applications (e.g. antibody–drug conjugates, prodrugs, and nanocarriers) of these linkers. Furthermore, the article explores novel linker strategies for addressing tumor heterogeneity and drug resistance, and outlines the challenges and future directions for their application in delivering emerging therapeutic drugs.
- 23 April 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (37) , 9378-9390
Endogenous stimuli-responsive intelligent drug delivery systems: recent advances in cleavable linker design
Controllable drug release at target sites represents an important challenge in precision medicine. With advances in chemistry, materials, and biology, novel stimuli-responsive systems are being designed and fabricated for applications in biomedicine and pharmaceuticals. Endogenous biochemical signals, such as specific enzymes, pH, redox, and other species, provide natural targets for the development of stimuli-responsive intelligent drug delivery systems (DDSs). This review deeply analyzes the cleavable linkers that utilize these signals to trigger drug release. We explore the molecular design principles, chemical cleavage mechanisms, structure–activity relationships, and the applications (e.g. antibody–drug conjugates, prodrugs, and nanocarriers) of these linkers. Furthermore, the article explores novel linker strategies for addressing tumor heterogeneity and drug resistance, and outlines the challenges and future directions for their application in delivering emerging therapeutic drugs.
- 24 July 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 61 (61) , 11477-11480
Nucleus-targeted protein delivery via lysine dendron conjugation
A lysine dendron (LD)-mediated platform enables nuclear delivery of proteins via click chemistry, enhancing cellular uptake and antitumor efficacy in vitro/in vivo.
- 24 July 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 61 (61) , 11477-11480
Nucleus-targeted protein delivery via lysine dendron conjugation
A lysine dendron (LD)-mediated platform enables nuclear delivery of proteins via click chemistry, enhancing cellular uptake and antitumor efficacy in vitro/in vivo.
- 25 June 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 60 (57) , 7335-7338
Self-assembly of enzymes and prodrugs with clickable amino acids for nucleus-targeted cancer therapy
A nucleus-targeted nanocomposite was prepared by clickable amino acid-tuned one-step co-assembly of proteins and chemotherapeutics. The nanocomposite with favorable pharmacokinetic behavior can effectively accumulate in the nucleus, thereby significantly enhancing the anticancer therapeutic effect both in vitro and in vivo.
- 25 June 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 60 (57) , 7335-7338
Self-assembly of enzymes and prodrugs with clickable amino acids for nucleus-targeted cancer therapy
A nucleus-targeted nanocomposite was prepared by clickable amino acid-tuned one-step co-assembly of proteins and chemotherapeutics. The nanocomposite with favorable pharmacokinetic behavior can effectively accumulate in the nucleus, thereby significantly enhancing the anticancer therapeutic effect both in vitro and in vivo.
- 20 February 2024
- Published by Royal Society of Chemistry (RSC) in Organic Chemistry Frontiers
- Vol. 11 (8) , 2215-2219
A formal (3 + 2) annulation–Cannizzaro cascade of bifunctional peroxides for the synthesis of dihydrofurans
A complicated Michael addition–epoxidation–cyclization–Cannizzaro cascade of 2-formylallyl peroxides and β-keto esters has been developed under mild KOH basic conditions, which produces a pair of 2,2-bis(hydroxymethyl) and 2-carboxyl-2-hydroxymethyl dihydrofurans in good total yields. By switching to K2CO3 basic conditions, the reaction alternatively provides formyl epoxides in good yields via a Michael addition–epoxidation cascade. Detailed mechanistic investigations and the synthetic utility of the obtained products are also demonstrated.
- 20 February 2024
- Published by Royal Society of Chemistry (RSC) in Organic Chemistry Frontiers
- Vol. 11 (8) , 2215-2219
A formal (3 + 2) annulation–Cannizzaro cascade of bifunctional peroxides for the synthesis of dihydrofurans
A complicated Michael addition–epoxidation–cyclization–Cannizzaro cascade of 2-formylallyl peroxides and β-keto esters has been developed under mild KOH basic conditions, which produces a pair of 2,2-bis(hydroxymethyl) and 2-carboxyl-2-hydroxymethyl dihydrofurans in good total yields. By switching to K2CO3 basic conditions, the reaction alternatively provides formyl epoxides in good yields via a Michael addition–epoxidation cascade. Detailed mechanistic investigations and the synthetic utility of the obtained products are also demonstrated.
- 15 August 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 59 (73) , 10940-10943
Nucleus-selective self-augmenting cascade nanoassemblies for targeted synergistic photo-chemo therapy of tumors
The HPC-CAT/CL-Ap nanocomposite entered into tumor cell by endocytosis and quickly accumulate in the nucleus, thereby significantly inhibiting tumor growth and lung metastasis by self-augmenting cascade photo-chemo therapy.
- 15 August 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 59 (73) , 10940-10943
Nucleus-selective self-augmenting cascade nanoassemblies for targeted synergistic photo-chemo therapy of tumors
The HPC-CAT/CL-Ap nanocomposite entered into tumor cell by endocytosis and quickly accumulate in the nucleus, thereby significantly inhibiting tumor growth and lung metastasis by self-augmenting cascade photo-chemo therapy.
- 10 August 2023
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 11 (19) , 6436-6456
Research progress in nucleus-targeted tumor therapy
An overview of the strategies and applications of nuclear-targeted therapy.
- 10 August 2023
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 11 (19) , 6436-6456
Research progress in nucleus-targeted tumor therapy
An overview of the strategies and applications of nuclear-targeted therapy.
- Top Cited PapersOpen Access
- 5 June 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (23) , eaba7406
Noninvasive in vivo 3D bioprinting
The subcutaneously injected bioink was noninvasively printed into customized living tissue constructs in situ.
- 5 June 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (23) , eaba7406
Top Cited PapersOpen AccessNoninvasive in vivo 3D bioprinting
The subcutaneously injected bioink was noninvasively printed into customized living tissue constructs in situ.